54
Investigation of chronic diarrhoea British Society of Gastroenterology Guidelines 2 nd Edition 2003 Dr. P.D. Thomas Consultant Gastroenterologist Taunton and Somerset Hospital

Updated BSG guidelines for investigation of

Embed Size (px)

Citation preview

Page 1: Updated BSG guidelines for investigation of

Investigation of chronic diarrhoeaBritish Society of Gastroenterology

Guidelines 2nd Edition 2003

Dr. P.D. ThomasConsultant Gastroenterologist

Taunton and Somerset Hospital

Page 2: Updated BSG guidelines for investigation of

Outline● Definitions● Initial assessment ● Factitious diarrhoea● Functional bowel problems● Colonic investigations● Small bowel investigations

● Investigation of fat and carbohydrate malabsorption● Investigation of malabsorption due to pancreatic

insufficiency● Specific conditions

small bowel bacterial overgrowth, bile salt malabsorption, hormone secreting tumours

Page 3: Updated BSG guidelines for investigation of

Mechanisms

• Intestinal secretions and food- 7l per day• 5L absorbed in small intestine• 1.5-2L absorbed by colon• Stool 100-200mL water• 10% decrease in fluid absorbed by colon will

double stool volume• Considerable reserve capacity of colon to absorb

increased ileal effluent

Page 4: Updated BSG guidelines for investigation of
Page 5: Updated BSG guidelines for investigation of

Approaches to the classification of diarrhoea

• MechanisticOsmotic - eg carbohydrate/ fat malabsorptionSecretory- mucosal disease, defects of ion

absorption, stimulant laxativesGut hormone

Deranged motility - post vagtomy, IBS carcinoid

Page 6: Updated BSG guidelines for investigation of

• Distinguishing osmotic from secretorydiarrhoea

- fasting - osmotic diarrhoea should stop

- osmotic gaplow stool osmolality <290 mosmol/kg

suggests contamination with hypotonic fluid290-2x (Na and K conc)Osmotic gap >125mosmol/kg osmotic diarrhoea

<50 in secretory diarrhoea

Page 7: Updated BSG guidelines for investigation of

• Anatomical …...

Page 8: Updated BSG guidelines for investigation of

Causes of diarrhoeaColonic

Colonic neoplasia EndocrineUlcerative and Crohn's colitis HyperthyroidismMicroscopic colitis Diabetes

Small bowel HypoparathyroidismCoeliac disease Addison's diseaseCrohn's disease Hormone secreting tumours (VIPoma, Other small bowel enteropathies, gastrinoma, carcinoid)(e.g. Whipples disease, tropical sprue, amyloid, intestinal lymphangiectasia )

Bile Acid malabsorptionDisaccharidase deficiencySmall bowel bacterial overgrowthMesenteric ischaemiaRadiation enteritis OtherLymphoma Factitious diarrhoeaGiardiasis Surgical' causes (e.g. small bowel

Pancreatic resections)Chronic pancreatitis Autonomic neuropathy Pancreatic carcinoma DrugsCystic fibrosis Alcohol

Page 9: Updated BSG guidelines for investigation of

Definitions

● >200g stool/24 hours

● More than three loose stools/day

● Chronic > 4 weeks

● Layman’s definition

Page 10: Updated BSG guidelines for investigation of

Initial assessment

• Organic vs functional<3 months, continuous, nocturnal, alarm symptoms

• Malabsorptive or colonic/inflammatory

• SpecificDrugs, family history, surgery, systemic disease,

alcohol, infective

Page 11: Updated BSG guidelines for investigation of

Initial investigations

• Blood testsFBC, UE, LFT, B12, folate, fe studies, ESR, CRP, TFT

• Serological tests for coeliac diseasePrevalence of 1:200 in asymptomatic western pops. IgA anti-endomysium antibodies

anti-tissue transglutaminase antibodies

Page 12: Updated BSG guidelines for investigation of

Stool tests

• Stool microscopy cultureProtozoal eg Giardia, amobae, cryptosporidia

• Non specificStool osmolalitystool fat

• Specificstool elastaseother..

Page 13: Updated BSG guidelines for investigation of

• Stool markers of intestinal inflammatione.g. lactoferrin

• Stool calprotectincytosolic protein in monocytes, neutrophilsstable for 1 week at RT

• Use of surrogate markers of inflammtion and Rome criteria to distinguish organic from non-organic disease Tibble et al Gastroenetrology 2002

Page 14: Updated BSG guidelines for investigation of

• N=602 all patients underwent invasive imaging Ix

Rome criteria, Intestinal permeability• Results

263 organic disease, 339 IBS Sensitivity

specificitystool calprotectin 89 79intestinal permeability 63 87Rome criteria 85 71

Page 15: Updated BSG guidelines for investigation of

Factitious diarrhoea

● 4% of patients attending district gastroenterology clinic

● 20-33% attending tertiary referral centres● Association with medical training/eating disorder● In patient assessment/monitoring

- stool collections- 24-48 hour fast

● ‘Laxative screen’ - anthraquinones, biascodyl,phenolphthaleins, oils, Mg, PO4.

Page 16: Updated BSG guidelines for investigation of

Case 1

• 50 year old female• 6 months watery diarrhoea up 6 x day• Normal baseline investigations including TFT,

coeliac serology• Normal flexible sigmoidoscopy with bx 2 years

ago

Next investigation?

Page 17: Updated BSG guidelines for investigation of

Microscopic colitis

• Lymphocytic or collagenous colitis

• Rectosigmoid biopsies alone may miss up to 40% of cases (Offner1999)

Page 18: Updated BSG guidelines for investigation of

C o l o n i c S m a l l b o w e l P a n c r e a t i c

C h r o n i c d i a r r h o e a

FrequencyAgeMalignancy

Page 19: Updated BSG guidelines for investigation of

Overlap between functional and organic disease

• Irritable Bowel syndromeRome criteria (II) > 3 months

abdominal pain or discomfort with 2 or more - altered stool frequency

- altered stool consistency- relieved by defecation

bloating or distention or mucous supportive

Page 20: Updated BSG guidelines for investigation of
Page 21: Updated BSG guidelines for investigation of

Discriminant factors

• >45• Family history

• <45• Female sex• Other ‘functional’ Sx

Irritable bowel Colonic pathology

Page 22: Updated BSG guidelines for investigation of

Chronic diarrhoea in patients <45yrs

• Flexible sigmoidoscopy Fine et al 2000

800 patients studied Microscopic colitis 10% >Crohn’s >UC 99.7% of pathology accessible with FS

Page 23: Updated BSG guidelines for investigation of

Chronic diarrhoea in patients >45yrsRationale for total colonic examination

• Neoplasia 37% asymptomatic

individuals have adenomas 8% adenomas>1cm(Lieberman 2000) Prevalence in symptomatic?

• Higher prevalence of proximal non-neoplastic pathology

e.g microscopic colitis, IBD7-31%

• Colonoscopy or barium enema and flexi sigmoidoscopy

Page 24: Updated BSG guidelines for investigation of

Case 2

• 40 year old male• Loose offensive stools 4x/day

? ½ stone weight loss 1 year• FBC, LFT, CRP etc normal• IgA Antiendomysial antibodies negative • Flexible sigmoidoscopy normal

Page 25: Updated BSG guidelines for investigation of

• Selective IgA deficiency 0.14% population2.6% coeliac disease

• IgG antiendomysium Abor IgG anti-tTG Ab are suitable alternative serological tests

• Check IgA levels

Page 26: Updated BSG guidelines for investigation of

Endoscopic distal duodenal biopsies

• Little information on diagnostic yield• Serological tests have replaced D2 biopsies as the

initial investigation for coeliac disease • Coeliac disease is (by far) the most common

small bowel enteropathy in western europeanpopulations BUT other small bowel

enteropathies should be considered. ‘D2

biopsies where small bowel malabsorption is clinically suspected’

Page 27: Updated BSG guidelines for investigation of

Case 3

• 55 year old male• RIF pain and diarrhoea• Tenderness RIF• Baseline Ix NAD except CRP 32• Colonoscopy incomplete (histology normal)

Next step?

Page 28: Updated BSG guidelines for investigation of

Terminal ileal diseaseHow to assess?

Page 29: Updated BSG guidelines for investigation of

Small bowel imaging

• Barium follow through Enteroclysis

-yield low, equivalent role -small bowel

malabsorption suspected (distal duodenal histology normal)Structural abnormalities

Page 30: Updated BSG guidelines for investigation of

Small bowel imaging (2)

• Tc- HMPAO labelled white cell scanning

• Enteroscopydiagnostic yield up to 31% ( 20% if

gastroscopically accessible lesionsexcluded)

Page 31: Updated BSG guidelines for investigation of

Small bowel imaging (3)

• Capsule endoscopy?Established role in the investigation of

iron deficiency anaemia? Suspected small bowel malabsorption

or diarrhoea of unknown cause

• Superior to small bowel barium XR70% vs 40% diagnostic yield

Page 32: Updated BSG guidelines for investigation of

Capsule Endoscopy:Detection of inflammatory lesions

in the small intestine

Thickened infiltrated folds (Jejunum) Villous erosion

Linear ulcerationsApthous ulcerations (ileum)

Page 33: Updated BSG guidelines for investigation of

Capsule endoscopic diagnosis of Crohn’s Disease

Jejunal Crohn's Disease

Page 34: Updated BSG guidelines for investigation of

CELIAC DISEASE

Page 35: Updated BSG guidelines for investigation of

INVESTIGATION OF CHRONIC DIARRHOEA

Basic investigationsFBC, LFT, Ca, B12, Folate, Fe status, TFT

Coeliac serology

History suggestive of organicdiarrhoea

Abnormal basic investigations

Symptoms suggestive of functionaldisease

Age <45,normal basic investigationsirritable bowel syndrome

History or findings c/w malabsorptionHistory or findings c/w colonic

disease or small bowel inflammatorydisease

'Difficult diarrhoea'Suspicion of laxative abuse

persistent symptoms despite negative IxHigh volume diarrhoea

Small BowelD2 biopsy

Barium follow throughPancreatic

EnteropathyReview histology?Enteroscopy

Or capsule endoscopy

Flexible sigmoidoscopy if <45Complement with barium enema if >45

Colonoscopy preferred if >45

Terminal ileal disease excluded?Barium follow through

99mTc-HMPAO75SeHCAT

Page 36: Updated BSG guidelines for investigation of

Malabsorption and ‘difficult diarrhoea’

Page 37: Updated BSG guidelines for investigation of

‘‘Malabsorption’’

Malabsorption - mucosal disease

carbohydrate>fat

Maldigestion - pancreatic disease

fat> carbohydrate

(protein quantification difficult)

Page 38: Updated BSG guidelines for investigation of

Tests related to fat malabsorption (1)

Stool tests● 3 day faecal fat (poorly reproducible)

patients with steatorrhoea reduce fat intakeno assessment of completeness of collectionno quality control

● faecal fat concentration (not widely available)● Stool steatocrit and Sudan III (semi-quantitative)

all are non-specific

Page 39: Updated BSG guidelines for investigation of

Tests of fat malabsorption (2)

Breath tests● 14C-triolein ● 13C-hiolein Lembke 1996

8-12 hr , 30 min breath samplessensitivity 92% in severe, 46% in mild/mod

pancreatic insufficiency● 13C- mixed chain triglyceride● Only sensitive if moderate or severe steatorrhoea

Page 40: Updated BSG guidelines for investigation of

Tests related to carbohydrate malabsorption

● D-xylose - used in assessment of mucosal disease for 30 years

- High sensitivity (98%) and specificity (95%) reported (although controvercial)

- 5 hour urine collection and/or 1 hour serum sample

● D-xylose breath test

Both have been largely replaced by endoscopic distal duodenal biopsies

Page 41: Updated BSG guidelines for investigation of

Chronic pancreatitis

• Usually obvious• Previous episodes of

pancreatitis• History of XS alcohol• Weight loss• Steatorrhoea• Coincident diabetes?

Page 42: Updated BSG guidelines for investigation of

Investigation of pancreatic malabsorption: Imaging

• USS50-60% sensitive

• CT74-90% sensitive

• ERCP ‘Gold standard’

• MRI?equivalent to ERCP

Page 43: Updated BSG guidelines for investigation of

Investigation of pancreatic malabsorption

Invasive ● Pancreatic function tests

- Secretin/cholecystokinin stimulation- ‘Lundh’ test

Sensitivity 90%● ERCP

secretin-cholecystokinin ERCP26/30 abnormal 21/30

Page 44: Updated BSG guidelines for investigation of

Investigation of pancreatic malabsorption

Non-invasive (1)● (all tests related to fat malabsorption)● (Serum enzymes)● Faecal tests

- chymotrypsin (Sens 80% Spec 84%)- lipase (sensitivity 46%)- elastase

mild moderate severe sensitivity 63 100 100% (Loser 1996)

40 33 82% (Lankisch 1998)

Page 45: Updated BSG guidelines for investigation of

Investigation of pancreatic malabsorption

Non-invasive (2)‘Tubeless’ oral pancreatic function tests● NBTP/PABA

- N-benzoyl-L-tyrosyl-p-aminobenzoic acid - hydrolysed by chymotrypsin- 6 hour urine collection- Sensitivity 64-83% Specificity 89%

● Fluorescein dilaurate (Pancreolauryl) test- Pancreatic esterase- 10 hour urine collection- variable sensitivities reported

Page 46: Updated BSG guidelines for investigation of

Investigation of pancreatic malabsorption (summary)

• Faecal elastase is the non-invasive investigationof choice

• May complement with Urine test such as pancreolauryl or NBTP-PABA but - specificity influenced by small bowel disease - technically more demanding

Page 47: Updated BSG guidelines for investigation of

Miscellaneous causes and ‘difficult diarrhoea’

• Small bowel bacterial overgrowth• Bile acid malabsorption• Hormone secreting tumours

Page 48: Updated BSG guidelines for investigation of

Small bowel bacterial overgrowth

● Underdiagnosed -few data on prevalence- Up to 50% of patients with gastrojejeunostomy- Resection of ileo-caecal valve eg pouch patients- 14% asymptomatic elderly by glucose HBT

● Small bowel aspirate and culture - ‘Gold standard’ >10^6 cfu/mL- Culture of anaerobes difficult- May overestimate -contamination and ‘normal’ small bowel colonisation by bacteria.

Page 49: Updated BSG guidelines for investigation of

Investigation of small bowel bacterial overgrowth

● Breath tests- 14C-cholylglycine - now abandoned- Hydrogen breath tests (glucose or lactulose)

Sensitivity: 17 - 68%Specificity: 70-83%

- 14C-D xylose – not available in UKProximally absorbedNo reliance on H2 production

Page 50: Updated BSG guidelines for investigation of

Bile acid malabsorption

• Causesterminal ileal disease, surgical resection primary defect, post cholecystectomyrapid transport

• 75Se homotaurocholate (75SeHCAT)synthetic analogue of taurocholic acidretained fraction assessed by gamma camera 7 days after oral administration<15% suggest BAM

• 7alphahydroxy-4-cholestone-3-one• Therapeutic trial of cholestyramine

Page 51: Updated BSG guidelines for investigation of

Hormone secreting tumours

• Rare! Incidence approx. 1 per million

• VIPoma, gastrinoma, carcinoid, somatostatinoma• Large volumes (>1 litre) of watery diarrhoea• VIPoma

90% are pancreatic, large tumoursDiarrhoea primary symptom (100%)Can be episodic. Secretory diarrhoeaFasting VIP level >170pg/mL

Page 52: Updated BSG guidelines for investigation of

Summary I N V E S T I G A T I O N O F C H R O N I C D I A R R H O E A

E n t e r o p a t h yR e v i e w h i s t o l o g y

? E n t e r o s c o p y

B a c t e r i a l o v e r g r o w t hG l u c o s e h y d r o g e n b r e a t h t e s tJ e j e u n a l a s p i r a t e a n d c u l t u r e

S m a l l B o w e lD 2 b i o p s y

B a r i u m f o l l o w t h r o u g h

F u r t h e r s t r u c t u r a l t e s t sE R C P o r M R C P

P a n c r e a t i cC T p a n c r e a s

f a e c a l e l a s t a s e o r c h y m o t r y p s i nP a n c r e o l a u r y l t e s t

H i s t o r y o r f i n d i n g s c / w m a l a b s o r p t i o n

T e r m i n a l i l e a l d i s e a s e e x c l u d e d ?B a r i u m f o l l o w t h r o u g h

9 9 m T c - H M P A O7 5 S e H C A T

F l e x i b l e s i g m o i d o s c o p y i f < 4 5C o m p l e m e n t w i t h b a r i u m e n e m a i f > 4 5

C o l o n o s c o p y p r e f e r r e d i f > 4 5

H i s t o r y o r f i n d i n g s c / w c o l o n i cd i s e a s e

G u t h o r m o n e sS e r u m g a s t r i n , V I P

U r i n a r y 5 H I A A

C o n s i d e r i n - p a t i e n t a s s e s s m e n t2 4 - 7 2 h r s s t o o l w e i g h t s

S t o o l o s m o l a l i t y / o s m o t i c g a pL a x a t i v e s c r e e n

' D i f f i c u l t d i a r r h o e a 'S u s p i c i o n o f l a x a t i v e a b u s e

p e r s i s t e n t s y m p t o m s d e s p i t e n e g a t i v e I xH i g h v o l u m e d i a r r h o e a

H i s t o r y s u g g e s t i v e o f o r g a n i cd i a r r h o e a

A b n o r m a l b a s i c i n v e s t i g a t i o n s

S y m p t o m s s u g g e s t i v e o f f u n c t i o n a ld i s e a s e

A g e < 4 5 , n o r m a l b a s i c i n v e s t i g a t i o n si r r i t a b l e b o w e l s y n d r o m e

B a s i c i n v e s t i g a t i o n sF B C , L F T , C a , B 1 2 , F o l a t e , F e s t a t u s , T F T

C o e l i a c s e r o l o g y

Page 53: Updated BSG guidelines for investigation of

Conclusions● Baseline investigations (primary care)● lower GI endoscopy with biopsy● Consider factitious diarrhoea● Small bowel malabsorption

- Distal duodenal biopsies- small bowel imaging

● Pancreatic insufficiency- faecal elastase, Pancreolauryl test, pancreatic imaging

● Other – SB bacterial overgrowth, BAM etc

In 1/3 patients no diagnosis made:‘chronic idiopathic diarrhoea’

Page 54: Updated BSG guidelines for investigation of